Supernus Pharmaceuticals (SUPN) Capital Expenditures (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted Capital Expenditures of $568,000 for Q2 2026, up 24.8% from $455,000 a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Capital Expenditures (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Supernus Pharmaceuticals was $1.12 million, down 5.9% year-over-year; for FY2025, it came in at $1.34 million, up 84.6% from FY2024.
- Annual Capital Expenditures has increased for three consecutive years, though with a five-year compound annual growth rate of -17.3% (FY2020 to FY2025).
- In prior years, Supernus Pharmaceuticals' Capital Expenditures was $725,000 in FY2024 (+31.6%), $551,000 in FY2023 (+33.7%) and $412,000 in FY2022.
- The Q2 2026 figure stands as the highest quarterly Capital Expenditures since Q1 2022.
- On a year-over-year basis, Capital Expenditures increased in five of the last six quarters, with growth averaging 127.7%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2025, with growth of 610.9%; the weakest was Q1 2023, with a decline of 67.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Supernus Pharmaceuticals | 2.56 Bn | 1.21 Bn | 185.39 Mn | 568,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 568,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Sep 30, 2025 | 129,000.00 |
| Jun 30, 2025 | 455,000.00 |
| Mar 31, 2025 | 327,000.00 |
| Dec 31, 2024 | 213,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 248,000.00 |
| Dec 31, 2023 | -36,000.00 |
| Sep 30, 2023 | 150,000.00 |
| Jun 30, 2023 | 159,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Sep 30, 2022 | 147,000.00 |
| Jun 30, 2022 | -576,000.00 |
| Mar 31, 2022 | 851,000.00 |
| Mar 31, 2021 | 1.51 Mn |
| Dec 31, 2020 | 215,000.00 |
| Sep 30, 2020 | 162,000.00 |
API Access
Supernus Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();